A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
Yu Lin(University of Michigan–Ann Arbor), David M. Lubman(University of Michigan), Ana Huerta(Hospital Universitario Puerta de Hierro Majadahonda), Amit G. Singal(Southwestern Medical Center), Neehar D. Parikh(University of Michigan), Jie Zhang(Yan'an University)
Cited by 15
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
|Nature Chemistry|2015|305
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177